• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

14-3-3η 蛋白在类风湿关节炎中的作用:有前途的诊断标志物和骨质疏松的独立危险因素。

14-3-3η Protein in Rheumatoid Arthritis: Promising Diagnostic Marker and Independent Risk Factor for Osteoporosis.

机构信息

The First Affiliated Hospital of Nanchang University.

Key Laboratory of Laboratory Medicine in Jiangxi Province, Department of Clinical Laboratory, the Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Lab Med. 2020 Sep 1;51(5):529-539. doi: 10.1093/labmed/lmaa001.

DOI:10.1093/labmed/lmaa001
PMID:32080735
Abstract

BACKGROUND

Early identification and disease monitoring are challenges facing rheumatologists in the management of rheumatoid arthritis (RA).

METHODS

We utilized enzyme-linked immunosorbent assay (ELISA) to determine 14-3-3η and anticyclic citrullinated peptide antibody (anti-CCP) levels, with rheumatoid factor (RF) level detected by rate nephelometry. The diagnostic value of each index was determined via receiver operating characteristic (ROC) curve, and the association between 14-3-3η and osteoporosis was assessed using multiple logistic regression analysis.

RESULTS

Serum levels of 14-3-3η were 3.26 ng per mL in patients with RA. These levels were helpful in identifying patients with the disease, with the area under the curve (AUC) being 0.879 and 0.853, respectively, from all healthy control individuals and patients with RA. Combining 14-3-3η with RF or anti-CCP increased the diagnostic rate. Logistic regression analysis identified 14-3-3η as an independent risk factor for RA-related osteoporosis (odds ratio [OR], 1.503; 95% confidence interval [CI], 1.116-2.025; P <.01).

CONCLUSIONS

Serum 14-3-3η detection by itself or combined with other serum indices was helpful in differentiating patients with RA. Also, it was a promising biomarker for disease monitoring in RA.

摘要

背景

早期识别和疾病监测是风湿科医生在类风湿关节炎(RA)管理中面临的挑战。

方法

我们利用酶联免疫吸附试验(ELISA)测定了 14-3-3η 和抗环瓜氨酸肽抗体(抗-CCP)的水平,类风湿因子(RF)的水平通过速率散射比浊法检测。通过接收者操作特征(ROC)曲线确定每个指标的诊断价值,并通过多元逻辑回归分析评估 14-3-3η 与骨质疏松症的关系。

结果

RA 患者血清 14-3-3η 水平为 3.26ng/mL。这些水平有助于识别患有该疾病的患者,曲线下面积(AUC)分别为 0.879 和 0.853,来自所有健康对照个体和 RA 患者。将 14-3-3η 与 RF 或抗-CCP 结合使用可提高诊断率。逻辑回归分析确定 14-3-3η 是 RA 相关骨质疏松症的独立危险因素(比值比[OR],1.503;95%置信区间[CI],1.116-2.025;P<.01)。

结论

单独或联合其他血清指标检测血清 14-3-3η 有助于区分 RA 患者。此外,它是 RA 疾病监测的有前途的生物标志物。

相似文献

1
14-3-3η Protein in Rheumatoid Arthritis: Promising Diagnostic Marker and Independent Risk Factor for Osteoporosis.14-3-3η 蛋白在类风湿关节炎中的作用:有前途的诊断标志物和骨质疏松的独立危险因素。
Lab Med. 2020 Sep 1;51(5):529-539. doi: 10.1093/labmed/lmaa001.
2
Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.血清14-3-3η可提高类风湿关节炎的诊断率并与疾病活动相关。
Ann Clin Lab Sci. 2019 Jan;49(1):57-62.
3
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.血清14-3-3η是一种新型标志物,可补充当前的血清学检测方法,以提高类风湿性关节炎患者的检测率。
J Rheumatol. 2014 Nov;41(11):2104-13. doi: 10.3899/jrheum.131446. Epub 2014 Aug 15.
4
Elevated serum 14-3-3η protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.血清 14-3-3η 蛋白升高可能有助于诊断中国人群中与继发性骨质疏松症相关的早期类风湿关节炎。
Clin Rheumatol. 2017 Nov;36(11):2581-2587. doi: 10.1007/s10067-017-3807-2. Epub 2017 Sep 5.
5
Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.14-3-3η蛋白、高迁移率族蛋白B1、抗环瓜氨酸肽抗体、抗突变瓜氨酸波形蛋白抗体及类风湿因子在类风湿关节炎中的临床诊断意义
Br J Biomed Sci. 2020 Jan;77(1):19-23. doi: 10.1080/09674845.2019.1658425. Epub 2019 Sep 16.
6
14-3-3η protein: a promising biomarker for rheumatoid arthritis.14-3-3η 蛋白:类风湿关节炎有前途的生物标志物。
Biomark Med. 2018 Aug;12(8):917-925. doi: 10.2217/bmm-2017-0385. Epub 2018 Jul 19.
7
Evaluation of Serum Protein 14-3-3η (Eta) as a Novel Biomarker for Rheumatoid Arthritis.血清蛋白14-3-3η(伊塔)作为类风湿性关节炎新型生物标志物的评估
Egypt J Immunol. 2019 Jan;26(1):163-175.
8
Diagnostic performance of 14-3-3η and anti-carbamylated protein antibodies in Rheumatoid Arthritis in Han population of Northern China.14-3-3η 和抗氨甲酰化蛋白抗体在我国北方汉族人群类风湿关节炎中的诊断性能。
Clin Chim Acta. 2020 Mar;502:102-110. doi: 10.1016/j.cca.2019.12.011. Epub 2019 Dec 17.
9
14-3-3η: a novel biomarker platform for rheumatoid arthritis.14-3-3η:类风湿性关节炎的新型生物标志物平台
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-35-9. Epub 2014 Oct 30.
10
Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3η protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis.与抗环瓜氨酸肽(CCP)抗体和抗微小病毒B19衣壳蛋白(MCV)抗体相比,血清含胶原三螺旋重复序列-1(CTHRC1)和14-3-3η蛋白在类风湿关节炎诊断中的价值。
Br J Biomed Sci. 2021 Apr;78(2):67-71. doi: 10.1080/09674845.2020.1810400. Epub 2020 Sep 7.

引用本文的文献

1
Investigation of Novel Therapeutic Targets for Rheumatoid Arthritis Through Human Plasma Proteome.通过人类血浆蛋白质组研究类风湿关节炎的新型治疗靶点
Biomedicines. 2025 Jul 29;13(8):1841. doi: 10.3390/biomedicines13081841.
2
Evaluation of 14-3-3eta protein as a diagnostic biomarker in the initial assessment of inflammatory arthritis.评估14-3-3η蛋白作为炎症性关节炎初始评估中的诊断生物标志物。
J Rheum Dis. 2025 Apr 1;32(2):130-135. doi: 10.4078/jrd.2024.0110. Epub 2024 Dec 4.
3
Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases.
14-3-3 蛋白的多功能性及其在骨骼和关节相关疾病中的作用。
Bone Res. 2024 Oct 15;12(1):58. doi: 10.1038/s41413-024-00370-4.
4
Serum 14‑3‑3η levels are increased and associated with a higher risk of osteoporosis in patients with rheumatoid arthritis: A meta‑analysis.血清14-3-3η水平升高与类风湿关节炎患者骨质疏松风险增加相关:一项荟萃分析。
Exp Ther Med. 2023 Dec 27;27(2):76. doi: 10.3892/etm.2023.12364. eCollection 2024 Feb.
5
Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis.miR-142-3P 通过抑制 14-3-3η 来调节 MAPK 蛋白家族,从而增强骨髓间充质干细胞的成骨作用。
Sci Rep. 2023 Dec 21;13(1):22862. doi: 10.1038/s41598-023-48950-4.
6
14-3-3η protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis.14-3-3η蛋白与类风湿关节炎患者的疾病活动度及骨质疏松相关。
Reumatologia. 2022;60(6):384-391. doi: 10.5114/reum.2022.123669. Epub 2022 Dec 30.
7
The Role of 14-3-3 η as a Biomarker in Rheumatoid Arthritis.14-3-3η作为类风湿关节炎生物标志物的作用
Rheumatol Immunol Res. 2021 Sep 28;2(2):87-90. doi: 10.2478/rir-2021-0012. eCollection 2021 Jun.
8
Diagnostic accuracy of 14-3-3 η protein in rheumatoid arthritis: A meta-analysis.14-3-3η 蛋白在类风湿关节炎中的诊断准确性:一项荟萃分析。
Int J Rheum Dis. 2020 Nov;23(11):1443-1451. doi: 10.1111/1756-185X.13921. Epub 2020 Sep 10.